Inhibition	O
of	O
T	B-cell_type
cell	I-cell_type
and	O
promotion	O
of	O
natural	O
killer	O
cell	O
development	O
by	O
the	O
dominant	B-protein
negative	I-protein
helix	I-protein
loop	I-protein
helix	I-protein
factor	I-protein
Id3	B-protein
.	O

Bipotential	B-cell_type
T/natural	I-cell_type
killer	I-cell_type
(	I-cell_type
NK	I-cell_type
)	I-cell_type
progenitor	I-cell_type
cells	I-cell_type
are	O
present	O
in	O
the	O
human	O
thymus	O
.	O

Despite	O
their	O
bipotential	O
capacity	O
,	O
these	O
progenitors	O
develop	O
predominantly	O
to	O
T	B-cell_type
cells	I-cell_type
in	O
the	O
thymus	O
.	O

The	O
mechanisms	O
controlling	O
this	O
developmental	O
choice	O
are	O
unknown	O
.	O

Here	O
we	O
present	O
evidence	O
that	O
a	O
member	O
(	O
s	O
)	O
of	O
the	O
family	O
of	O
basic	B-protein
helix	I-protein
loop	I-protein
helix	I-protein
(	I-protein
bHLH	I-protein
)	I-protein
transcription	I-protein
factors	I-protein
determines	O
lineage	O
specification	O
of	O
NK/T	B-cell_type
cell	I-cell_type
progenitors	I-cell_type
.	O

The	O
natural	O
dominant	B-protein
negative	I-protein
HLH	I-protein
factor	I-protein
Id3	B-protein
,	O
which	O
blocks	O
transcriptional	O
activity	O
of	O
a	O
number	O
of	O
known	O
bHLH	B-protein
factors	I-protein
,	O
was	O
expressed	O
in	O
CD34+	B-cell_type
progenitor	I-cell_type
cells	I-cell_type
by	O
retrovirus-mediated	O
gene	O
transfer	O
.	O

Constitutive	O
expression	O
of	O
Id3	B-protein
completely	O
blocks	O
development	O
of	O
CD34+	B-cell_type
cells	I-cell_type
into	O
T	B-cell_type
cells	I-cell_type
in	O
a	O
fetal	O
thymic	O
organ	O
culture	O
(	O
FTOC	O
)	O
.	O

In	O
contrast	O
,	O
development	O
into	O
NK	B-cell_type
cells	I-cell_type
in	O
an	O
FTOC	O
is	O
enhanced	O
.	O

Thus	O
,	O
the	O
activity	O
of	O
a	O
bHLH	B-protein
transcription	I-protein
factor	I-protein
is	O
necessary	O
for	O
T	O
lineage	O
differentiation	O
of	O
bipotential	B-cell_type
precursors	I-cell_type
,	O
in	O
the	O
absence	O
of	O
which	O
a	O
default	O
pathway	O
leading	O
to	O
NK	O
cell	O
development	O
is	O
chosen	O
.	O

Our	O
results	O
identify	O
a	O
molecular	O
switch	O
for	O
lineage	O
specification	O
in	O
early	B-cell_type
lymphoid	I-cell_type
precursors	I-cell_type
of	O
humans	O
.	O

Brief	NULL
Definitive	NULL
Report	NULL
Inhibition	NULL
of	NULL
T	NULL
Cell	NULL
and	NULL
Promotion	NULL
of	NULL
Natural	NULL
Killer	NULL
Cell	NULL
Development	NULL
by	NULL
the	NULL
Dominant	NULL
Negative	NULL
Helix	NULL
Loop	NULL
Helix	NULL
Factor	NULL
Id3	NULL
By	NULL
Mirjam	NULL
H.M.	NULL
Heemskerk	NULL
,	NULL
*	NULL
Bianca	NULL
Blom	NULL
,	NULL
*	NULL
Garry	NULL
Nolan	NULL
,	NULL
:	NULL
Alexander	NULL
PA.	NULL
Stegmann	NULL
,	NULL
*	NULL
Arjen	NULL
Q.	NULL
Bakker	NULL
,	NULL
*	NULL
Kees	NULL
Weijer	NULL
,	NULL
*	NULL
Pieter	NULL
C.	NULL
M.	NULL
Res	NULL
,	NULL
*	NULL
and	NULL
Hergen	NULL
Spits*	NULL
From	NULL
the	NULL
*Division	NULL
of	NULL
Immunology	NULL
,	NULL
T	NULL
he	NULL
N	NULL
etherlands	NULL
Cancer	NULL
Institute	NULL
,	NULL
Plesmanlaan	NULL
121	NULL
,	NULL
1066	NULL
CX	NULL
Amsterdam	NULL
,	NULL
T	NULL
he	NULL
N	NULL
etherlands	NULL
;	NULL
and	NULL
*Department	NULL
of	NULL
Pharmacology	NULL
,	NULL
Stanford	NULL
University	NULL
,	NULL
Palo	NULL
Alta	NULL
Califomia	NULL
Sum	NULL
m	NULL
ary	NULL
Bipotential	NULL
T/	NULL
natural	NULL
killer	NULL
(	NULL
NK	NULL
)	NULL
progenitor	NULL
cells	NULL
are	NULL
present	NULL
in	NULL
the	NULL
human	NULL
thymus	NULL
.	NULL

Despite	NULL
their	NULL
bipotential	NULL
capacity	NULL
,	NULL
these	NULL
progenitors	NULL
develop	NULL
predominantly	NULL
to	NULL
T	NULL
cells	NULL
in	NULL
the	NULL
thymus	NULL
.	NULL

The	NULL
mechanisms	NULL
controlling	NULL
this	NULL
developmental	NULL
choice	NULL
are	NULL
unknown	NULL
.	NULL

Here	NULL
we	NULL
present	NULL
evidence	NULL
that	NULL
a	NULL
member	NULL
(	NULL
s	NULL
)	NULL
of	NULL
the	NULL
family	NULL
of	NULL
basic	NULL
helix	NULL
loop	NULL
helix	NULL
(	NULL
bHLH	NULL
)	NULL
transcription	NULL
factors	NULL
determines	NULL
lineage	NULL
specification	NULL
of	NULL
NK/T	NULL
cell	NULL
progenitors	NULL
.	NULL

The	NULL
natural	NULL
dominant	NULL
negative	NULL
HLH	NULL
factor	NULL
Id3	NULL
,	NULL
which	NULL
blocks	NULL
transcriptional	NULL
activity	NULL
of	NULL
a	NULL
number	NULL
of	NULL
known	NULL
bHLH	NULL
factors	NULL
,	NULL
was	NULL
expressed	NULL
in	NULL
CD34+*	NULL
progenitor	NULL
cells	NULL
by	NULL
retrovirus-	NULL
mediated	NULL
gene	NULL
transfer	NULL
.	NULL

Constitutive	NULL
expression	NULL
of	NULL
Id3	NULL
completely	NULL
blocks	NULL
development	NULL
of	NULL
CD34	NULL
*	NULL
cells	NULL
into	NULL
T	NULL
cells	NULL
in	NULL
a	NULL
fetal	NULL
thymic	NULL
organ	NULL
culture	NULL
(	NULL
FTOC	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
development	NULL
into	NULL
NK	NULL
cells	NULL
in	NULL
an	NULL
FTOC	NULL
is	NULL
enhanced	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
activity	NULL
of	NULL
a	NULL
bHLH	NULL
transcription	NULL
factor	NULL
is	NULL
necessary	NULL
for	NULL
T	NULL
lineage	NULL
differentiation	NULL
of	NULL
bipotential	NULL
precursors	NULL
,	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
which	NULL
a	NULL
default	NULL
pathway	NULL
leading	NULL
to	NULL
NK	NULL
cell	NULL
development	NULL
is	NULL
cho-sen.	NULL
O	NULL
ur	NULL
results	NULL
identify	NULL
a	NULL
molecular	NULL
switch	NULL
for	NULL
lineage	NULL
specification	NULL
in	NULL
early	NULL
lymphoid	NULL
precur-	NULL
sors	NULL
of	NULL
humans	NULL
.	NULL

he	NULL
earliest	NULL
progenitor	NULL
cells	NULL
in	NULL
the	NULL
thymus	NULL
have	NULL
the	NULL
ca	NULL
pacity	NULL
of	NULL
developing	NULL
into	NULL
multiple	NULL
hematopoietic	NULL
lineages	NULL
.	NULL

Upon	NULL
further	NULL
development	NULL
within	NULL
the	NULL
thymus	NULL
,	NULL
these	NULL
progenitor	NULL
cells	NULL
progressively	NULL
lose	NULL
their	NULL
multipotentiality	NULL
(	NULL
1	NULL
)	NULL
.	NULL

There	NULL
is	NULL
considerable	NULL
evidence	NULL
that	NULL
the	NULL
human	NULL
(	NULL
2	NULL
)	NULL
and	NULL
the	NULL
mouse	NULL
thymuses	NULL
(	NULL
3	NULL
,	NULL
4	NULL
)	NULL
contain	NULL
bipotential	NULL
T/	NULL
NK	NULL
progenitors	NULL
.	NULL

However	NULL
,	NULL
given	NULL
the	NULL
paucity	NULL
of	NULL
mature	NULL
NK	NULL
cells	NULL
in	NULL
the	NULL
thymus	NULL
,	NULL
the	NULL
thymic	NULL
environment	NULL
strongly	NULL
favors	NULL
development	NULL
of	NULL
these	NULL
bipotential	NULL
T/	NULL
NK	NULL
progenitor	NULL
cells	NULL
into	NULL
T	NULL
cells	NULL
The	NULL
molecular	NULL
mechanisms	NULL
controlling	NULL
T/	NULL
NK	NULL
lineage	NULL
specification	NULL
in	NULL
the	NULL
thymus	NULL
are	NULL
not	NULL
yet	NULL
elucidated	NULL
,	NULL
but	NULL
it	NULL
seems	NULL
fair	NULL
to	NULL
assume	NULL
that	NULL
this	NULL
developmental	NULL
choice	NULL
is	NULL
under	NULL
transcriptional	NULL
control	NULL
.	NULL

Several	NULL
transcription	NULL
factors	NULL
that	NULL
orchestrate	NULL
lymphoid	NULL
development	NULL
have	NULL
now	NULL
been	NULL
identified	NULL
in	NULL
the	NULL
mouse	NULL
.	NULL

Ikaros	NULL
is	NULL
a	NULL
key	NULL
factor	NULL
that	NULL
affects	NULL
development	NULL
of	NULL
all	NULL
lymphoid	NULL
(	NULL
T	NULL
,	NULL
NK	NULL
,	NULL
and	NULL
B	NULL
)	NULL
cells	NULL
(	NULL
5	NULL
)	NULL
.	NULL

Several	NULL
other	NULL
factors	NULL
appear	NULL
to	NULL
be	NULL
critical	NULL
for	NULL
development	NULL
of	NULL
specific	NULL
lymphoid	NULL
lineages	NULL
like	NULL
GAT	NULL
A-3	NULL
(	NULL
6	NULL
)	NULL
and	NULL
TCF-1	NULL
(	NULL
7	NULL
)	NULL
for	NULL
T	NULL
cells	NULL
and	NULL
Pax5	NULL
(	NULL
8	NULL
)	NULL
,	NULL
EBF	NULL
(	NULL
9	NULL
)	NULL
,	NULL
Sox4	NULL
(	NULL
10	NULL
)	NULL
,	NULL
and	NULL
the	NULL
products	NULL
of	NULL
the	NULL
E2A	NULL
gene	NULL
(	NULL
11	NULL
,	NULL
12	NULL
)	NULL
for	NULL
B	NULL
cells	NULL
The	NULL
E2A	NULL
proteins	NULL
E12	NULL
and	NULL
E47	NULL
belong	NULL
to	NULL
the	NULL
family	NULL
of	NULL
basic	NULL
helix	NULL
loop	NULL
helix	NULL
(	NULL
bHLH	NULL
)	NULL
transcription	NULL
factors	NULL
,	NULL
which	NULL
are	NULL
involved	NULL
in	NULL
differentiation	NULL
of	NULL
many	NULL
cell	NULL
types	NULL
1597	NULL
(	NULL
13	NULL
)	NULL
.	NULL

E12	NULL
and	NULL
E47	NULL
probably	NULL
regulate	NULL
B	NULL
cell	NULL
development	NULL
by	NULL
controlling	NULL
expression	NULL
of	NULL
immunoglobulin	NULL
,	NULL
RAG	NULL
,	NULL
and	NULL
a	NULL
number	NULL
of	NULL
B	NULL
cell-specific	NULL
genes	NULL
including	NULL
mb-1	NULL
,	NULL
A5	NULL
,	NULL
CD19	NULL
,	NULL
and	NULL
Pax5	NULL
(	NULL
11	NULL
,	NULL
12	NULL
,	NULL
14	NULL
)	NULL
.	NULL

Transcriptional	NULL
activity	NULL
of	NULL
bHLH	NULL
factors	NULL
is	NULL
controlled	NULL
by	NULL
the	NULL
inhibitor	NULL
of	NULL
DNA	NULL
binding	NULL
(	NULL
Id	NULL
)	NULL
proteins	NULL
.	NULL

This	NULL
family	NULL
of	NULL
HLH	NULL
factors	NULL
comprises	NULL
four	NULL
members	NULL
,	NULL
Id1	NULL
,	NULL
2	NULL
,	NULL
3	NULL
,	NULL
and	NULL
4	NULL
,	NULL
which	NULL
are	NULL
highly	NULL
homolo-gous	NULL
in	NULL
their	NULL
HLH	NULL
domains	NULL
and	NULL
have	NULL
distinct	NULL
tissue	NULL
distributions	NULL
(	NULL
15	NULL
,	NULL
16	NULL
)	NULL
.	NULL

Id	NULL
factors	NULL
can	NULL
heterodimerize	NULL
with	NULL
bHLH	NULL
factors	NULL
,	NULL
but	NULL
lack	NULL
a	NULL
basic	NULL
DNA	NULL
binding	NULL
domain	NULL
,	NULL
and	NULL
therefore	NULL
they	NULL
block	NULL
transcriptional	NULL
activity	NULL
by	NULL
bHLH	NULL
factors	NULL
.	NULL

Constitutive	NULL
overexpression	NULL
of	NULL
Id1	NULL
under	NULL
control	NULL
of	NULL
a	NULL
B	NULL
cell-specific	NULL
mb-1	NULL
promotor	NULL
leads	NULL
to	NULL
inhibition	NULL
of	NULL
B	NULL
cell	NULL
development	NULL
(	NULL
17	NULL
)	NULL
,	NULL
similar	NULL
to	NULL
the	NULL
one	NULL
observed	NULL
in	NULL
E2A-deficient	NULL
animals	NULL
(	NULL
11	NULL
,	NULL
12	NULL
)	NULL
.	NULL

R	NULL
ecent	NULL
evidence	NULL
has	NULL
suggested	NULL
a	NULL
role	NULL
for	NULL
bHLH	NULL
factors	NULL
in	NULL
development	NULL
of	NULL
T	NULL
cells	NULL
as	NULL
well	NULL
.	NULL

E2A-deficient	NULL
mice	NULL
were	NULL
initially	NULL
reported	NULL
to	NULL
have	NULL
no	NULL
gross	NULL
abnormalities	NULL
in	NULL
T	NULL
cell	NULL
development	NULL
,	NULL
but	NULL
the	NULL
size	NULL
of	NULL
the	NULL
thymus	NULL
is	NULL
smaller	NULL
than	NULL
that	NULL
of	NULL
wild-type	NULL
animals	NULL
(	NULL
12	NULL
)	NULL
.	NULL

Mice	NULL
deficient	NULL
for	NULL
another	NULL
bHLH	NULL
factor	NULL
,	NULL
HEB	NULL
,	NULL
displayed	NULL
a	NULL
partial	NULL
block	NULL
in	NULL
T	NULL
cell	NULL
development	NULL
at	NULL
an	NULL
early	NULL
stage	NULL
of	NULL
development	NULL
(	NULL
18	NULL
)	NULL
.	NULL

Whether	NULL
HEB	NULL
and	NULL
E2A	NULL
deficiencies	NULL
affect	NULL
NK	NULL
cell	NULL
development	NULL
is	NULL
not	NULL
known	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

©	NULL
The	NULL
R	NULL
ockefeller	NULL
University	NULL
Press	NULL
«	NULL
0022-1007/	NULL
97/	NULL
11/	NULL
1597/06	NULL
$	NULL
2.00	NULL
Volume	NULL
186	NULL
,	NULL
Number	NULL
9	NULL
,	NULL
November	NULL
3	NULL
,	NULL
1997	NULL
1597-1602	NULL
http	NULL
:	NULL
//	NULL
www.jem.org	NULL
In	NULL
this	NULL
paper	NULL
we	NULL
have	NULL
investigated	NULL
the	NULL
role	NULL
of	NULL
bHLH	NULL
factors	NULL
in	NULL
human	NULL
T	NULL
and	NULL
NK	NULL
cell	NULL
development	NULL
.	NULL

We	NULL
have	NULL
made	NULL
use	NULL
of	NULL
retrovirus-	NULL
mediated	NULL
gene	NULL
transfer	NULL
to	NULL
enforce	NULL
expression	NULL
of	NULL
one	NULL
of	NULL
the	NULL
Id	NULL
proteins	NULL
,	NULL
Id3	NULL
,	NULL
in	NULL
CD34+*	NULL
progenitors	NULL
using	NULL
a	NULL
bicistronic	NULL
vector	NULL
harboring	NULL
Id3	NULL
and	NULL
the	NULL
marker	NULL
gene	NULL
green	NULL
fluorescent	NULL
protein	NULL
(	NULL
GFP	NULL
)	NULL
.	NULL

Id3	NULL
can	NULL
interact	NULL
with	NULL
a	NULL
wide	NULL
range	NULL
of	NULL
bHLH	NULL
factors	NULL
and	NULL
blocks	NULL
transcriptional	NULL
activity	NULL
of	NULL
E12	NULL
,	NULL
E47	NULL
,	NULL
and	NULL
HEB	NULL
(	NULL
19	NULL
)	NULL
.	NULL

We	NULL
found	NULL
that	NULL
enforced	NULL
expression	NULL
of	NULL
Id3	NULL
strongly	NULL
inhibits	NULL
development	NULL
of	NULL
CD34¢*	NULL
progenitors	NULL
to	NULL
CD3¢*	NULL
T	NULL
cells	NULL
in	NULL
an	NULL
in	NULL
vitro	NULL
fetal	NULL
thymic	NULL
organ	NULL
culture	NULL
(	NULL
FTOC	NULL
)	NULL
,	NULL
but	NULL
promotes	NULL
development	NULL
of	NULL
NK	NULL
cells	NULL
.	NULL

Materials	NULL
and	NULL
Methods	NULL
Construction	NULL
of	NULL
the	NULL
V	NULL
edtors	NULL
and	NULL
T	NULL
ransduction	NULL
of	NULL
Target	NULL
Cells	NULL
.	NULL

Previously	NULL
we	NULL
have	NULL
successfully	NULL
used	NULL
bicistronic	NULL
vectors	NULL
with	NULL
a	NULL
gene	NULL
of	NULL
interest	NULL
linked	NULL
to	NULL
a	NULL
downstream	NULL
internal	NULL
ribosomal	NULL
entry	NULL
site	NULL
(	NULL
IRES	NULL
)	NULL
and	NULL
a	NULL
marker	NULL
gene	NULL
that	NULL
allow	NULL
independent	NULL
translation	NULL
of	NULL
the	NULL
products	NULL
of	NULL
both	NULL
genes	NULL
in	NULL
the	NULL
transduced	NULL
target	NULL
cells	NULL
(	NULL
20	NULL
)	NULL
.	NULL

The	NULL
IR	NULL
ES-GFP	NULL
sequence	NULL
was	NULL
ligated	NULL
into	NULL
the	NULL
LZR	NULL
S	NULL
vector	NULL
(	NULL
21	NULL
)	NULL
,	NULL
and	NULL
a	NULL
polylinker	NULL
was	NULL
placed	NULL
downstream	NULL
of	NULL
the	NULL
gag	NULL
and	NULL
upstream	NULL
of	NULL
the	NULL
IRES	NULL
sequences	NULL
.	NULL

The	NULL
Id3	NULL
coding	NULL
sequence	NULL
was	NULL
cloned	NULL
from	NULL
the	NULL
pCDN	NULL
AId3	NULL
(	NULL
gift	NULL
of	NULL
Dr.	NULL
C.	NULL
Murre	NULL
,	NULL
University	NULL
of	NULL
California	NULL
at	NULL
San	NULL
Diego	NULL
,	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
)	NULL
plasmid	NULL
by	NULL
PCR	NULL
using	NULL
oligonucle-otide	NULL
primers	NULL
with	NULL
appropriate	NULL
linkers	NULL
.	NULL

The	NULL
product	NULL
was	NULL
ligated	NULL
between	NULL
the	NULL
Xhol	NULL
and	NULL
SnaBI	NULL
site	NULL
of	NULL
the	NULL
polylinker	NULL
from	NULL
our	NULL
plasmid	NULL
LZR	NULL
S-linker-IRES-GFP	NULL
,	NULL
to	NULL
obtain	NULL
the	NULL
retroviral	NULL
vector	NULL
LZR	NULL
S-Id3-IRES-GFP	NULL
.	NULL

(	NULL
A	NULL
modified	NULL
version	NULL
of	NULL
GFP	NULL
[	NULL
enhanced	NULL
GFP	NULL
]	NULL
was	NULL
used	NULL
in	NULL
this	NULL
study	NULL
and	NULL
was	NULL
obtained	NULL
from	NULL
Clontech	NULL
,	NULL
Palo	NULL
Alto	NULL
,	NULL
CA	NULL
.	NULL
)	NULL

Helper-free	NULL
recombinant	NULL
retrovirus	NULL
was	NULL
produced	NULL
after	NULL
transfection	NULL
into	NULL
a	NULL
293T	NULL
-based	NULL
amphotropic	NULL
retroviral	NULL
packaging	NULL
cell	NULL
line	NULL
,	NULL
Phoenix	NULL
(	NULL
21	NULL
)	NULL
.	NULL

Purified	NULL
CD34*	NULL
cells	NULL
were	NULL
cultured	NULL
for	NULL
24	NULL
h	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
10	NULL
ng/ml	NULL
human	NULL
IL-7	NULL
and	NULL
10	NULL
ng/ml	NULL
stem	NULL
cell	NULL
factor	NULL
(	NULL
SCF	NULL
)	NULL
(	NULL
both	NULL
from	NULL
R	NULL
&	NULL
D	NULL
,	NULL
Abingdon	NULL
,	NULL
UK	NULL
)	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
then	NULL
transduced	NULL
by	NULL
overnight	NULL
incubation	NULL
with	NULL
virus	NULL
supernatant	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
10	NULL
ug/ml	NULL
Dotap	NULL
(	NULL
Boehringer	NULL
Mannheim	NULL
GmbH	NULL
,	NULL
Mannheim	NULL
,	NULL
Germany	NULL
)	NULL
.	NULL

Isolation	NULL
of	NULL
CD34*	NULL
Cells	NULL
from	NULL
Fetal	NULL
Liver	NULL
and	NULL
Postnatal	NULL
Thymus	NULL
.	NULL

-	NULL
Fetal	NULL
liver	NULL
was	NULL
obtained	NULL
from	NULL
elective	NULL
therapeutic	NULL
abor-tions	NULL
.	NULL

Gestational	NULL
age	NULL
was	NULL
determined	NULL
by	NULL
crown-rump	NULL
length	NULL
and	NULL
ranged	NULL
from	NULL
14	NULL
to	NULL
17	NULL
wk	NULL
.	NULL

The	NULL
use	NULL
of	NULL
this	NULL
tissue	NULL
was	NULL
approved	NULL
by	NULL
the	NULL
medical	NULL
ethical	NULL
committee	NULL
of	NULL
the	NULL
Netherlands	NULL
Cancer	NULL
Institute	NULL
and	NULL
was	NULL
contingent	NULL
upon	NULL
informed	NULL
consent	NULL
.	NULL

Human	NULL
fetal	NULL
liver	NULL
cells	NULL
were	NULL
isolated	NULL
by	NULL
gentle	NULL
disruption	NULL
of	NULL
the	NULL
tissue	NULL
by	NULL
mechanical	NULL
means	NULL
,	NULL
followed	NULL
by	NULL
density	NULL
gradient	NULL
centrifugation	NULL
over	NULL
Fi-coll-Hypaque	NULL
(	NULL
Lymphoprep	NULL
;	NULL
Nycomed	NULL
Pharma	NULL
,	NULL
Oslo	NULL
,	NULL
Norway	NULL
)	NULL
.	NULL

The	NULL
CD34*	NULL
cells	NULL
were	NULL
isolated	NULL
from	NULL
these	NULL
samples	NULL
by	NULL
immuno-magnetic	NULL
cell	NULL
sorting	NULL
,	NULL
using	NULL
a	NULL
CD34	NULL
separation	NULL
kit	NULL
(	NULL
varioMACS	NULL
;	NULL
Miltenyi	NULL
Biotec	NULL
,	NULL
Bergisch	NULL
Gladbach	NULL
,	NULL
Germany	NULL
)	NULL
and	NULL
were	NULL
further	NULL
purified	NULL
by	NULL
sorting	NULL
with	NULL
a	NULL
FAC	NULL
Star	NULL
plus®	NULL
(	NULL
Becton	NULL
Dickinson	NULL
,	NULL
San	NULL
José	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Postnatal	NULL
thymus	NULL
samples	NULL
were	NULL
from	NULL
children	NULL
undergoing	NULL
open-heart	NULL
surgery	NULL
.	NULL

CD34*	NULL
cells	NULL
,	NULL
enriched	NULL
by	NULL
immuno-magnetic	NULL
cell	NULL
sorting	NULL
,	NULL
were	NULL
labeled	NULL
with	NULL
anti-CD34	NULL
(	NULL
HPCA-2	NULL
;	NULL
Becton	NULL
Dickinson	NULL
)	NULL
and	NULL
anti-CD1a	NULL
(	NULL
Coulter	NULL
,	NULL
Hialeah	NULL
,	NULL
FL	NULL
)	NULL
antibodies	NULL
and	NULL
the	NULL
CD34*CD1a~	NULL
cells	NULL
were	NULL
purified	NULL
by	NULL
FACS®	NULL
sort-ing	NULL
.	NULL

The	NULL
purity	NULL
of	NULL
the	NULL
populations	NULL
used	NULL
in	NULL
this	NULL
study	NULL
was	NULL
>	NULL
99	NULL
%	NULL
.	NULL

Fetal	NULL
Thymic	NULL
Organ	NULL
Cultures	NULL
.	NULL

-	NULL
In	NULL
vitro	NULL
development	NULL
of	NULL
human	NULL
T	NULL
and	NULL
NK	NULL
cells	NULL
from	NULL
CD34*	NULL
fetal	NULL
liver	NULL
cells	NULL
or	NULL
thymocytes	NULL
was	NULL
studied	NULL
using	NULL
the	NULL
hybrid	NULL
human/mouse	NULL
FTOC	NULL
using	NULL
fetal	NULL
thymuses	NULL
from	NULL
embryos	NULL
of	NULL
R	NULL
AG-	NULL
1-deficient	NULL
mice	NULL
as	NULL
described	NULL
(	NULL
22	NULL
)	NULL
.	NULL

TCR-y/8*	NULL
and	NULL
NK	NULL
cells	NULL
were	NULL
expanded	NULL
in	NULL
Yssels	NULL
medium	NULL
(	NULL
23	NULL
)	NULL
1598	NULL
from	NULL
the	NULL
FTOC	NULL
cultures	NULL
using	NULL
a	NULL
feeder	NULL
cell	NULL
mixture	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
24	NULL
)	NULL
.	NULL

NK	NULL
Cell	NULL
Assays	NULL
.	NULL

10,000	NULL
CD34*	NULL
sorted	NULL
cells	NULL
were	NULL
cultured	NULL
in	NULL
Yssels	NULL
medium	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
10	NULL
ng/	NULL
ml	NULL
SCF	NULL
,	NULL
10	NULL
ng/	NULL
ml	NULL
IL-7	NULL
,	NULL
and	NULL
100	NULL
U/ml	NULL
IL-2	NULL
(	NULL
Eurocetus	NULL
,	NULL
Amsterdam	NULL
,	NULL
Netherlands	NULL
)	NULL
.	NULL

After	NULL
1	NULL
wk	NULL
,	NULL
cells	NULL
were	NULL
harvested	NULL
,	NULL
counted	NULL
,	NULL
and	NULL
analyzed	NULL
by	NULL
FACS®	NULL
,	NULL
using	NULL
anti-CD3	NULL
and	NULL
anti-CD56	NULL
(	NULL
provided	NULL
by	NULL
Dr.	NULL
J.H	NULL
.	NULL

Phillips	NULL
,	NULL
DNAX	NULL
,	NULL
Palo	NULL
Alto	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

The	NULL
cytotoxic	NULL
activity	NULL
of	NULL
NK	NULL
cells	NULL
was	NULL
determined	NULL
with	NULL
a	NULL
standard	NULL
``	NULL
Cr-release	NULL
assay	NULL
using	NULL
cells	NULL
of	NULL
NK-sensitive	NULL
(	NULL
K562	NULL
)	NULL
and	NULL
insensitive	NULL
(	NULL
the	NULL
EBV-transformed	NULL
B	NULL
cell	NULL
line	NULL
EBV225	NULL
)	NULL
cell	NULL
lines	NULL
as	NULL
target	NULL
cells	NULL
.	NULL

Analysis	NULL
of	NULL
D-JB	NULL
Rearngements	NULL
.	NULL

D-JB	NULL
rearrangements	NULL
were	NULL
determined	NULL
by	NULL
PCR	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
25	NULL
)	NULL
.	NULL

Primers	NULL
and	NULL
probes	NULL
used	NULL
for	NULL
TCR-B	NULL
rearrangement	NULL
were	NULL
:	NULL
5-TGGTGGTC-TCTCCCAGGCTCT-3	NULL
'	NULL
(	NULL
PDBI.1	NULL
)	NULL
,	NULL
5-CCAGCTGTCCAGC-CTTGACTT-3	NULL
'	NULL
(	NULL
JB1.3-1.4	NULL
)	NULL
and	NULL
5-CAAAGCTGTAACAT-TGTGGGGAC-3	NULL
'	NULL
(	NULL
DB	NULL
,	NULL
,	NULL
probe	NULL
)	NULL
.	NULL

To	NULL
control	NULL
for	NULL
the	NULL
amount	NULL
of	NULL
DNA	NULL
in	NULL
the	NULL
PCR	NULL
,	NULL
genomic	NULL
amplification	NULL
of	NULL
the	NULL
RAG-2	NULL
gene	NULL
was	NULL
performed	NULL
.	NULL

Primers	NULL
and	NULL
probe	NULL
used	NULL
were	NULL
:	NULL
5-TGTGAATTGCA-CAGTCTTGCCAGG-3	NULL
'	NULL
(	NULL
RAG-2	NULL
sense	NULL
)	NULL
,	NULL
5-GGGTTTGT-TGAGCTCAGTTGAATAG-3	NULL
'	NULL
(	NULL
RAG-2	NULL
antisense	NULL
)	NULL
,	NULL
and	NULL
5'-CAAGATATGGTTTGGAAGCAACATGGGAAA-3	NULL
``	NULL
(	NULL
RAG-2	NULL
probe	NULL
)	NULL
.	NULL

Results	NULL
and	NULL
Discussion	NULL
Enforced	NULL
Expression	NULL
of	NULL
Id3	NULL
Inhibits	NULL
Development	NULL
of	NULL
CD1a	NULL
-	NULL
Thymocytes	NULL
,	NULL
but	NULL
Promotes	NULL
NK	NULL
Development	NULL
in	NULL
an	NULL
FTOC	NULL
.	NULL

To	NULL
study	NULL
the	NULL
role	NULL
of	NULL
bHLH	NULL
factors	NULL
in	NULL
T	NULL
cell	NULL
development	NULL
,	NULL
we	NULL
overexpressed	NULL
the	NULL
dominant	NULL
negative	NULL
HLH	NULL
protein	NULL
Id3	NULL
in	NULL
T	NULL
cell	NULL
progenitors	NULL
and	NULL
monitored	NULL
the	NULL
fate	NULL
of	NULL
the	NULL
transduced	NULL
cells	NULL
.	NULL

Id3	NULL
has	NULL
a	NULL
very	NULL
broad	NULL
tissue	NULL
distribution	NULL
and	NULL
CD34*	NULL
fetal	NULL
liver	NULL
and	NULL
thymic	NULL
progenitor	NULL
cells	NULL
express	NULL
Id3	NULL
messenger	NULL
RN	NULL
A	NULL
as	NULL
determined	NULL
by	NULL
reverse	NULL
transcription	NULL
PCR	NULL
(	NULL
results	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Purified	NULL
CD34¢*	NULL
fetal	NULL
liver	NULL
cells	NULL
were	NULL
cultured	NULL
with	NULL
a	NULL
combination	NULL
of	NULL
SCF	NULL
and	NULL
IL-7	NULL
for	NULL
24	NULL
h.	NULL
The	NULL
cells	NULL
were	NULL
then	NULL
transduced	NULL
by	NULL
overnight	NULL
coculture	NULL
with	NULL
supernatants	NULL
of	NULL
packaging	NULL
cells	NULL
producing	NULL
recombinant	NULL
viruses	NULL
harboring	NULL
either	NULL
Id3-IRES-GFP	NULL
or	NULL
IRES-GFP	NULL
,	NULL
and	NULL
cultured	NULL
in	NULL
an	NULL
FTOC	NULL
for	NULL
4	NULL
wk	NULL
(	NULL
22	NULL
)	NULL
.	NULL

The	NULL
flow	NULL
cytometric	NULL
analysis	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
demonstrates	NULL
that	NULL
the	NULL
GFP	NULL
marker	NULL
was	NULL
transferred	NULL
to	NULL
23	NULL
%	NULL
of	NULL
the	NULL
progeny	NULL
of	NULL
the	NULL
IR	NULL
ES-GFP	NULL
and	NULL
13	NULL
%	NULL
of	NULL
the	NULL
Id3-IR	NULL
ES-GFP-transduced	NULL
progenitor	NULL
cells	NULL
.	NULL

The	NULL
patterns	NULL
of	NULL
CD3	NULL
,	NULL
CD4	NULL
,	NULL
and	NULL
CD5	NULL
stain-ings	NULL
of	NULL
the	NULL
GFP	NULL
*	NULL
cells	NULL
from	NULL
the	NULL
IR	NULL
ES-GFP-transduced	NULL
cells	NULL
are	NULL
identical	NULL
to	NULL
that	NULL
of	NULL
the	NULL
nontransduced	NULL
GFP-	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

The	NULL
great	NULL
majority	NULL
of	NULL
the	NULL
GFP	NULL
*	NULL
cells	NULL
express	NULL
CD	NULL
1a	NULL
,	NULL
and	NULL
very	NULL
few	NULL
CD56*	NULL
cells	NULL
were	NULL
present	NULL
in	NULL
these	NULL
samples	NULL
.	NULL

By	NULL
contrast	NULL
,	NULL
cells	NULL
harvested	NULL
from	NULL
the	NULL
FTOC	NULL
with	NULL
Id3-IRES-GFP-transduced	NULL
fetal	NULL
liver	NULL
cells	NULL
did	NULL
not	NULL
express	NULL
CD1a	NULL
,	NULL
and	NULL
32	NULL
%	NULL
of	NULL
these	NULL
cells	NULL
were	NULL
positive	NULL
for	NULL
the	NULL
NK	NULL
cell	NULL
marker	NULL
CD56	NULL
.	NULL

Almost	NULL
no	NULL
CD3*	NULL
cells	NULL
were	NULL
observed	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

Not	NULL
only	NULL
the	NULL
proportions	NULL
of	NULL
CD56*	NULL
cells	NULL
were	NULL
different	NULL
,	NULL
but	NULL
also	NULL
the	NULL
absolute	NULL
numbers	NULL
since	NULL
>	NULL
30-fold	NULL
more	NULL
GFP*CD56*	NULL
cells	NULL
were	NULL
found	NULL
in	NULL
the	NULL
FTOC	NULL
,	NULL
populated	NULL
with	NULL
Id3-transduced	NULL
CD34*	NULL
cells	NULL
.	NULL

These	NULL
data	NULL
indicate	NULL
that	NULL
CD34¢*	NULL
fetal	NULL
liver	NULL
cells	NULL
,	NULL
overexpressing	NULL
Id3	NULL
,	NULL
develop	NULL
preferentially	NULL
into	NULL
CD3-CD56¢*	NULL
cells	NULL
in	NULL
the	NULL
FTOC	NULL
.	NULL

It	NULL
was	NULL
important	NULL
to	NULL
ensure	NULL
that	NULL
these	NULL
GFP*CD3~CD56*	NULL
cells	NULL
represent	NULL
functional	NULL
NK	NULL
cells	NULL
.	NULL

To	NULL
obtain	NULL
enough	NULL
cells	NULL
for	NULL
testing	NULL
their	NULL
cy-	NULL
Id3	NULL
Inhibits	NULL
Human	NULL
T	NULL
Cell	NULL
Development	NULL
IRES-GFP	NULL
1d3-IRES-GFP	NULL
GFP	NULL
m	NULL
2	NULL
[	NULL
7	NULL
Pu	NULL
&	NULL
8	NULL
CD5S-TRC	NULL
E	NULL
Ba	NULL
mli	NULL
go	NULL
A	NULL
J	NULL
CD4-TRC	NULL
m	NULL
o	NULL
|	NULL
1	NULL
32	NULL
|	NULL
5	NULL
A.	NULL
a	NULL
#	NULL
2|6	NULL
~	NULL
ali	NULL
ig	NULL
>	NULL
.	NULL

A	NULL
CD3-TRC	NULL
Figure	NULL
1	NULL
.	NULL

_	NULL
Overexpression	NULL
of	NULL
Id3	NULL
inhibits	NULL
generation	NULL
of	NULL
T	NULL
cells	NULL
and	NULL
pro	NULL
motes	NULL
development	NULL
of	NULL
NK	NULL
cells	NULL
from	NULL
CD34	NULL
*	NULL
fetal	NULL
liver	NULL
cells	NULL
CD34	NULL
*	NULL
cells	NULL
were	NULL
isolated	NULL
,	NULL
transduced	NULL
with	NULL
viruses	NULL
harboring	NULL
IR	NULL
ES-GFP	NULL
or	NULL
Id3-IRES-GFP	NULL
,	NULL
and	NULL
incubated	NULL
with	NULL
mouse	NULL
thymic	NULL
lobes	NULL
at	NULL
10	NULL
``	NULL
celly	NULL
lobe	NULL
for	NULL
4	NULL
wk	NULL
.	NULL

Cell	NULL
supensions	NULL
were	NULL
stained	NULL
with	NULL
the	NULL
indicated	NULL
TriColor	NULL
(	NULL
TRC	NULL
)	NULL
and	NULL
PE-labeled	NULL
antibodies	NULL
and	NULL
analyzed	NULL
on	NULL
a	NULL
FAC	NULL
Scan®	NULL
.	NULL

Cell	NULL
recoveries	NULL
of	NULL
both	NULL
samples	NULL
were	NULL
3	NULL
X	NULL
10	NULL
``	NULL
celly	NULL
lobe	NULL
.	NULL

Percentages	NULL
of	NULL
transduced	NULL
cells	NULL
2	NULL
d	NULL
after	NULL
transduction	NULL
were	NULL
25	NULL
%	NULL
in	NULL
both	NULL
control-	NULL
and	NULL
Id3-transduced	NULL
samples	NULL
.	NULL

tolytic	NULL
activity	NULL
,	NULL
we	NULL
cultured	NULL
the	NULL
cells	NULL
harvested	NULL
from	NULL
the	NULL
FTOC	NULL
with	NULL
a	NULL
feeder	NULL
mixture	NULL
consisting	NULL
of	NULL
irradiated	NULL
PBMCs	NULL
,	NULL
the	NULL
EBV	NULL
cell	NULL
line	NULL
JY	NULL
,	NULL
PHA	NULL
and	NULL
IL-2	NULL
.	NULL

Under	NULL
these	NULL
conditions	NULL
we	NULL
can	NULL
expand	NULL
NK	NULL
cells	NULL
and	NULL
TCR-y/8	NULL
,	NULL
but	NULL
not	NULL
TCR	NULL
-	NULL
«	NULL
/	NULL
B	NULL
cells	NULL
from	NULL
an	NULL
FTOC	NULL
(	NULL
24	NULL
)	NULL
;	NULL
the	NULL
failure	NULL
to	NULL
obtain	NULL
TCR	NULL
-	NULL
«	NULL
/	NULL
B	NULL
cells	NULL
is	NULL
because	NULL
the	NULL
mouse	NULL
thymic	NULL
environment	NULL
is	NULL
unable	NULL
to	NULL
induce	NULL
functional	NULL
maturation	NULL
in	NULL
these	NULL
cells	NULL
(	NULL
24	NULL
)	NULL
.	NULL

Fig	NULL
.	NULL

2	NULL
demonstrates	NULL
that	NULL
the	NULL
GFP+	NULL
cells	NULL
expanded	NULL
from	NULL
the	NULL
control	NULL
FTOC	NULL
contained	NULL
GPF*	NULL
TCR	NULL
y/8*	NULL
cells	NULL
and	NULL
a	NULL
few	NULL
CD56*CD3~	NULL
cells	NULL
.	NULL

By	NULL
contrast	NULL
,	NULL
GFP*	NULL
cells	NULL
expanded	NULL
from	NULL
the	NULL
FTOC	NULL
with	NULL
the	NULL
Id3*	NULL
progenitor	NULL
cells	NULL
were	NULL
CD56*	NULL
and	NULL
did	NULL
not	NULL
express	NULL
CD3	NULL
,	NULL
underscoring	NULL
the	NULL
strong	NULL
inhibitory	NULL
effect	NULL
of	NULL
Id3	NULL
on	NULL
generation	NULL
of	NULL
TCR	NULL
cells	NULL
The	NULL
GFP*CD3~-CD56*	NULL
cells	NULL
were	NULL
sorted	NULL
from	NULL
the	NULL
Id3-IRES-GFP	NULL
cultures	NULL
and	NULL
were	NULL
shown	NULL
to	NULL
be	NULL
highly	NULL
cytotoxic	NULL
for	NULL
the	NULL
NK	NULL
sensitive	NULL
target	NULL
cell	NULL
K562	NULL
,	NULL
but	NULL
not	NULL
for	NULL
an	NULL
NK-resistant	NULL
cell	NULL
line	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
b	NULL
)	NULL
.	NULL

These	NULL
results	NULL
confirm	NULL
that	NULL
the	NULL
CD56*CD3-~GFP+*	NULL
cells	NULL
observed	NULL
in	NULL
these	NULL
FTOC	NULL
are	NULL
functional	NULL
NK	NULL
cells	NULL
.	NULL

The	NULL
observation	NULL
that	NULL
the	NULL
proportion	NULL
of	NULL
CD56*	NULL
cells	NULL
in	NULL
the	NULL
Id3-GFP+*	NULL
progeny	NULL
is	NULL
much	NULL
higher	NULL
than	NULL
in	NULL
the	NULL
control	NULL
GFP	NULL
progeny	NULL
and	NULL
in	NULL
the	NULL
Id3-GFP-	NULL
cells	NULL
in	NULL
the	NULL
FTOC	NULL
is	NULL
consistent	NULL
with	NULL
the	NULL
notion	NULL
that	NULL
Id3	NULL
overexpression	NULL
switches	NULL
the	NULL
cell	NULL
fate	NULL
of	NULL
the	NULL
bipotential	NULL
thymic	NULL
T/	NULL
NK	NULL
progenitors	NULL
.	NULL

An	NULL
alternative	NULL
possibility	NULL
is	NULL
that	NULL
overexpression	NULL
of	NULL
Id3	NULL
con	NULL
1599	NULL
Heemskerk	NULL
et	NULL
al	NULL
.	NULL

a	NULL
IRES-GFP	NULL
GFP	NULL
CD3-TRC	NULL
FCS	NULL
CDS56-PE	NULL
TCRy5-PE	NULL
Id3-IRES-GFP	NULL
CD3-TRC	NULL
GFP	NULL
FCS	NULL
CD56-PE	NULL
TCRy6-PE	NULL
Figure	NULL
2	NULL
.	NULL

CD56*	NULL
cells	NULL
generated	NULL
in	NULL
the	NULL
FTOC	NULL
from	NULL
Id3	NULL
trans	NULL
duced	NULL
CD34*	NULL
fetal	NULL
liver	NULL
cells	NULL
are	NULL
80	NULL
NK	NULL
cells	NULL
.	NULL

(	NULL
a	NULL
)	NULL
Id3-	NULL
and	NULL
control	NULL
transduced	NULL
cells	NULL
,	NULL
incubated	NULL
in	NULL
an	NULL
60	NULL
-	NULL
FTOC	NULL
,	NULL
were	NULL
harvested	NULL
4	NULL
wk	NULL
K562	NULL
later	NULL
,	NULL
and	NULL
expanded	NULL
with	NULL
a	NULL
feeder	NULL
cell	NULL
mixture	NULL
.	NULL

Percentages	NULL
of	NULL
GFP	NULL
*	NULL
40	NULL
1	NULL
cells	NULL
were	NULL
30	NULL
%	NULL
for	NULL
the	NULL
Id3-	NULL
and	NULL
40	NULL
%	NULL
for	NULL
the	NULL
control-transduced	NULL
cells	NULL
.	NULL

(	NULL
6	NULL
)	NULL
GFP+*	NULL
cells	NULL
of	NULL
the	NULL
Id3	NULL
transduced	NULL
culture	NULL
were	NULL
isolated	NULL
by	NULL
sorting	NULL
with	NULL
a	NULL
FAC	NULL
Star	NULL
plus®	NULL
and	NULL
tested	NULL
for	NULL
cytotoxic	NULL
activity	NULL
against	NULL
NK-sensitive	NULL
K562	NULL
cells	NULL
and	NULL
NK-insensitive	NULL
EBV	NULL
225	NULL
cells	NULL
in	NULL
a	NULL
``	NULL
Cr-release	NULL
assay	NULL
.	NULL

I	NULL
%	NULL
Specific	NULL
lysis	NULL
20	NULL
|	NULL
EBV	NULL
225	NULL
0	NULL
-+-	NULL
»	NULL
0.31	NULL
l:1	NULL
3:1	NULL
10:1	NULL
Effector	NULL
to	NULL
Target	NULL
cell	NULL
ratio	NULL
fers	NULL
a	NULL
growth	NULL
or	NULL
survival	NULL
advantage	NULL
to	NULL
developing	NULL
NK	NULL
cells	NULL
resulting	NULL
in	NULL
an	NULL
overrepresentation	NULL
of	NULL
these	NULL
cells	NULL
in	NULL
the	NULL
FTOC	NULL
.	NULL

To	NULL
investigate	NULL
this	NULL
,	NULL
we	NULL
studied	NULL
the	NULL
effect	NULL
of	NULL
Id3	NULL
transduction	NULL
on	NULL
development	NULL
of	NULL
CD34+*	NULL
fetal	NULL
liver	NULL
cells	NULL
into	NULL
NK	NULL
cells	NULL
in	NULL
a	NULL
mixture	NULL
of	NULL
SCF	NULL
,	NULL
IL-7	NULL
,	NULL
and	NULL
IL-2	NULL
(	NULL
2	NULL
)	NULL
.	NULL

All	NULL
cells	NULL
generated	NULL
from	NULL
transduced	NULL
CD34*	NULL
fetal	NULL
liver	NULL
cells	NULL
and	NULL
cultured	NULL
with	NULL
the	NULL
cytokines	NULL
for	NULL
2	NULL
wk	NULL
were	NULL
CD3~	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

In	NULL
both	NULL
Id3-IRES-GFP	NULL
and	NULL
the	NULL
IRES-GFP	NULL
cul-tures	NULL
,	NULL
we	NULL
observed	NULL
the	NULL
same	NULL
proportions	NULL
of	NULL
GFP+	NULL
cells	NULL
(	NULL
35	NULL
%	NULL
)	NULL
and	NULL
an	NULL
identical	NULL
distribution	NULL
of	NULL
CD56	NULL
in	NULL
the	NULL
IRES-GFP¢+*	NULL
and	NULL
the	NULL
Id3-IR	NULL
ES-GFP	NULL
*	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
constitutive	NULL
expression	NULL
of	NULL
Id3	NULL
in	NULL
the	NULL
CD34*	NULL
fetal	NULL
liver	NULL
cells	NULL
does	NULL
not	NULL
significantly	NULL
enhance	NULL
the	NULL
percentage	NULL
of	NULL
NK	NULL
cells	NULL
that	NULL
develop	NULL
under	NULL
the	NULL
influence	NULL
of	NULL
SCF	NULL
,	NULL
IL-7	NULL
,	NULL
and	NULL
IL-2	NULL
.	NULL

This	NULL
result	NULL
makes	NULL
it	NULL
unlikely	NULL
that	NULL
the	NULL
increase	NULL
of	NULL
NK	NULL
cell	NULL
numbers	NULL
observed	NULL
in	NULL
the	NULL
FTOC	NULL
with	NULL
Id3*	NULL
progenitor	NULL
cells	NULL
is	NULL
caused	NULL
by	NULL
improved	NULL
survival	NULL
or	NULL
proliferation	NULL
by	NULL
Id3	NULL
over-expression	NULL
.	NULL

TCR-B	NULL
rearrangements	NULL
are	NULL
initiated	NULL
in	NULL
the	NULL
CD1lat	NULL
CD3~CD4-CD8~CD34*	NULL
cells	NULL
(	NULL
25	NULL
,	NULL
26	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
CD1at	NULL
cells	NULL
are	NULL
unable	NULL
to	NULL
develop	NULL
into	NULL
NK	NULL
cells	NULL
(	NULL
2	NULL
)	NULL
.	NULL

This	NULL
suggests	NULL
that	NULL
upregulation	NULL
of	NULL
CD1a	NULL
is	NULL
correlated	NULL
with	NULL
T	NULL
cell	NULL
commitment	NULL
.	NULL

If	NULL
this	NULL
is	NULL
correct	NULL
and	NULL
if	NULL
overexpression	NULL
of	NULL
Id3	NULL
inhibits	NULL
T	NULL
cell	NULL
commitment	NULL
,	NULL
we	NULL
should	NULL
expect	NULL
that	NULL
CD1a~	NULL
CD34*	NULL
cells	NULL
transduced	NULL
with	NULL
Id3	NULL
fail	NULL
to	NULL
develop	NULL
into	NULL
T	NULL
cells	NULL
in	NULL
an	NULL
FTOC	NULL
.	NULL

Purified	NULL
CD1la~CD34¢*	NULL
cells	NULL
were	NULL
cultured	NULL
with	NULL
SCF	NULL
and	NULL
IL-7	NULL
,	NULL
transduced	NULL
,	NULL
and	NULL
incubated	NULL
in	NULL
an	NULL
FTOC	NULL
for	NULL
3	NULL
wk	NULL
.	NULL

Fig	NULL
.	NULL

4	NULL
demonstrates	NULL
that	NULL
the	NULL
control-transduced	NULL
cells	NULL
developed	NULL
normally	NULL
.	NULL

By	NULL
contrast	NULL
,	NULL
the	NULL
proportion	NULL
of	NULL
CD3*	NULL
cells	NULL
that	NULL
developed	NULL
from	NULL
Id3-transduced	NULL
CD1a~	NULL
Brief	NULL
Definitive	NULL
R	NULL
eport	NULL
IRES-GFP	NULL
Id3-IRES-GFP	NULL
sa|2	NULL
A	NULL
lsd	NULL
|6	NULL
a	NULL
O	NULL
Control-PE	NULL
3al2	NULL
oal	NULL
o	NULL
B4	NULL
&	NULL
O	NULL
CD3-PE	NULL
24112	NULL
23	NULL
]	NULL
14	NULL
a	NULL
26	NULL
]	NULL
37	NULL
27|36	NULL
E	NULL
&	NULL
CD56-PE	NULL
Figure	NULL
3	NULL
.	NULL

Overexpression	NULL
of	NULL
Id3	NULL
does	NULL
not	NULL
affect	NULL
NK	NULL
development	NULL
and	NULL
expansion	NULL
of	NULL
CD34*	NULL
fetal	NULL
liver	NULL
cells	NULL
incubated	NULL
in	NULL
IL-2	NULL
,	NULL
IL-7	NULL
,	NULL
and	NULL
SCF	NULL
.	NULL

CD34*	NULL
fetal	NULL
liver	NULL
cells	NULL
were	NULL
isolated	NULL
,	NULL
transduced	NULL
,	NULL
and	NULL
incubated	NULL
with	NULL
the	NULL
cytokines	NULL
for	NULL
14	NULL
d.	NULL
CD34*	NULL
cells	NULL
is	NULL
strongly	NULL
reduced	NULL
,	NULL
whereas	NULL
the	NULL
proportion	NULL
of	NULL
NK	NULL
cells	NULL
is	NULL
dramatically	NULL
increased	NULL
.	NULL

The	NULL
absolute	NULL
numbers	NULL
of	NULL
GFP+	NULL
NK	NULL
cells	NULL
in	NULL
the	NULL
Id3-transduced	NULL
samples	NULL
was	NULL
10-fold	NULL
higher	NULL
than	NULL
in	NULL
the	NULL
GFP*	NULL
cells	NULL
in	NULL
the	NULL
control-transduced	NULL
samples	NULL
.	NULL

The	NULL
inhibition	NULL
of	NULL
generation	NULL
of	NULL
CD3+*	NULL
by	NULL
Id3	NULL
is	NULL
underscored	NULL
by	NULL
the	NULL
almost	NULL
complete	NULL
absence	NULL
of	NULL
CD4¢*	NULL
and	NULL
CD4*CD8*	NULL
in	NULL
the	NULL
cells	NULL
expressing	NULL
Id3-GFP	NULL
.	NULL

The	NULL
CD8+	NULL
cells	NULL
observed	NULL
in	NULL
these	NULL
cultures	NULL
are	NULL
CD3~CD56*	NULL
cells	NULL
.	NULL

The	NULL
Id3-IRES-GFP*CD3-~CD56+*	NULL
could	NULL
be	NULL
expanded	NULL
with	NULL
a	NULL
feeder	NULL
cell	NULL
mixture	NULL
and	NULL
displayed	NULL
cytolytic	NULL
activity	NULL
against	NULL
K562	NULL
cells	NULL
(	NULL
results	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Enforced	NULL
Expression	NULL
of	NULL
Id3	NULL
Inhibits	NULL
Induation	NULL
of	NULL
D-JB	NULL
Rear	NULL
rangement	NULL
by	NULL
IL-7	NULL
and	NULL
SCF	NULL
.	NULL

T	NULL
cells	NULL
are	NULL
defined	NULL
by	NULL
TCR	NULL
gene	NULL
rearrangements	NULL
;	NULL
in	NULL
NK	NULL
cells	NULL
,	NULL
these	NULL
genes	NULL
are	NULL
in	NULL
the	NULL
germ	NULL
line	NULL
configuration	NULL
(	NULL
1	NULL
)	NULL
.	NULL

The	NULL
fact	NULL
that	NULL
Id3	NULL
inhibits	NULL
generation	NULL
of	NULL
CD3	NULL
*	NULL
cells	NULL
and	NULL
stimulates	NULL
that	NULL
of	NULL
NK	NULL
cells	NULL
,	NULL
raises	NULL
the	NULL
possibility	NULL
that	NULL
bHLH	NULL
factors	NULL
are	NULL
required	NULL
for	NULL
processes	NULL
that	NULL
result	NULL
in	NULL
TCR	NULL
rearrangements	NULL
.	NULL

To	NULL
test	NULL
this	NULL
,	NULL
we	NULL
cultured	NULL
transduced	NULL
CD1a~-CD34¢*	NULL
and	NULL
CD1atCD34*	NULL
cells	NULL
for	NULL
7	NULL
d	NULL
in	NULL
IL-7	NULL
and	NULL
SCF	NULL
,	NULL
sorted	NULL
GFP+	NULL
and	NULL
GFP-	NULL
cells	NULL
,	NULL
and	NULL
analyzed	NULL
for	NULL
the	NULL
presence	NULL
of	NULL
D-JB	NULL
rearrangements	NULL
with	NULL
a	NULL
sensitive	NULL
PCR	NULL
technique	NULL
(	NULL
25	NULL
)	NULL
.	NULL

Fig	NULL
.	NULL

5	NULL
shows	NULL
that	NULL
Id3	NULL
completely	NULL
blocked	NULL
IL-7	NULL
and	NULL
SCF-mediated	NULL
induction	NULL
of	NULL
D-JB	NULL
rearrangement	NULL
in	NULL
CD1a~-CD34*	NULL
cells	NULL
.	NULL

One	NULL
trivial	NULL
explanation	NULL
for	NULL
this	NULL
observation	NULL
is	NULL
that	NULL
SCF	NULL
and	NULL
IL-7	NULL
induce	NULL
growth	NULL
of	NULL
a	NULL
very	NULL
small	NULL
population	NULL
of	NULL
contaminating	NULL
CD1atCD34+*	NULL
cells	NULL
that	NULL
have	NULL
already	NULL
undergone	NULL
D-JB	NULL
rearrangements	NULL
;	NULL
overexpression	NULL
of	NULL
Id3	NULL
could	NULL
inhibit	NULL
the	NULL
growth	NULL
of	NULL
these	NULL
contaminating	NULL
cells	NULL
This	NULL
is	NULL
unlikely	NULL
because	NULL
D-JB	NULL
rearrangements	NULL
were	NULL
still	NULL
detectable	NULL
in	NULL
Id3-transduced	NULL
CD1atCD34+*	NULL
cells	NULL
recovered	NULL
after	NULL
7	NULL
d	NULL
of	NULL
culture	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

The	NULL
ratios	NULL
of	NULL
the	NULL
intensities	NULL
of	NULL
the	NULL
bands	NULL
hybridized	NULL
with	NULL
the	NULL
D-JB	NULL
and	NULL
genomic	NULL
DNA	NULL
control	NULL
(	NULL
R	NULL
AG-2	NULL
)	NULL
probes	NULL
in	NULL
the	NULL
starting	NULL
CD1a*	NULL
CD34*	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
and	NULL
in	NULL
the	NULL
Id3-CD1atCD34*	NULL
(	NULL
lane	NULL
6	NULL
)	NULL
populations	NULL
were	NULL
the	NULL
same	NULL
.	NULL

This	NULL
ratio	NULL
is	NULL
increased	NULL
in	NULL
the	NULL
un-transduced	NULL
CD1atCD34*	NULL
cells	NULL
These	NULL
data	NULL
indicate	NULL
that	NULL
IRES-GFP	NULL
Id3-IRES-GFP	NULL
Figure	NULL
4	NULL
.	NULL

Enforced	NULL
expression	NULL
of	NULL
Id3	NULL
in	NULL
CD1a=CD34*	NULL
thymocytes	NULL
blocks	NULL
T	NULL
cell	NULL
development	NULL
and	NULL
promotes	NULL
NK	NULL
develop	NULL
ment	NULL
in	NULL
an	NULL
FTOC	NULL
.	NULL

CD1a-CD34*	NULL
thymocytes	NULL
were	NULL
isolated	NULL
from	NULL
a	NULL
thymic	NULL
frag-	NULL
ment	NULL
of	NULL
a	NULL
6-mo-old	NULL
child	NULL
,	NULL
transduced	NULL
and	NULL
a	NULL
Br	NULL
\o	NULL
uo	NULL
A	NULL
&	NULL
E	NULL
n	NULL
%	NULL
o	NULL
A	NULL
J	NULL
E	NULL
1	NULL
25	NULL
1	NULL
[	NULL
17	NULL
0.510.5	NULL
B	NULL
46|28	NULL
45|37	NULL
95	NULL
]	NULL
4	NULL
el	NULL
cuss	NULL
&	NULL
&	NULL
E	NULL
#	NULL
1	NULL
incubated	NULL
in	NULL
a	NULL
FTOC	NULL
for	NULL
4	NULL
wk	NULL
at	NULL
104	NULL
celly	NULL
lobe	NULL
.	NULL

Cell	NULL
recoveries	NULL
were	NULL
5	NULL
X	NULL
10	NULL
``	NULL
and	NULL
6	NULL
X	NULL
10+	NULL
celly	NULL
lobe	NULL
for	NULL
the	NULL
Id3-	NULL
and	NULL
the	NULL
control-transduced	NULL
cells	NULL
,	NULL
respectively	NULL
.	NULL

Percentages	NULL
of	NULL
GFP*	NULL
cells	NULL
2	NULL
d	NULL
after	NULL
transduction	NULL
were	NULL
9	NULL
%	NULL
in	NULL
both	NULL
samples	NULL
.	NULL

Percentages	NULL
of	NULL
GFP+	NULL
cells	NULL
,	NULL
harvested	NULL
from	NULL
the	NULL
FTOC	NULL
,	NULL
were	NULL
7.2	NULL
%	NULL
in	NULL
the	NULL
control	NULL
and	NULL
2.4	NULL
%	NULL
in	NULL
the	NULL
Id3-transduced	NULL
CD3-TRC	NULL
samples	NULL
.	NULL

1600	NULL
__	NULL
Id3	NULL
Inhibits	NULL
Human	NULL
T	NULL
Cell	NULL
Development	NULL
CO34+CD1-_	NULL
_	NULL
CDM+CD1+	NULL
®	NULL
Figure	NULL
5	NULL
.	NULL

Enforced	NULL
expres	NULL
sion	NULL
of	NULL
Id3	NULL
in	NULL
CD34*CD1a~	NULL
thymocytes	NULL
inhibits	NULL
induction	NULL
of	NULL
D-JB	NULL
rearrangements	NULL
after	NULL
incu-	NULL
#	NULL
‘	NULL
.	NULL

—|	NULL
Tors	NULL
DJ	NULL
woe	NULL
mee	NULL
!	NULL

|	NULL
weg	NULL
,	NULL
|	NULL
(	NULL
**	NULL
pineemst	NULL
_	NULL
bation	NULL
in	NULL
IL-7	NULL
and	NULL
SCF	NULL
.	NULL

CD1a~	NULL
E	NULL
,	NULL
``	NULL
~	NULL
aﬁcioglgnlaﬂ	NULL
CaII3134+	NULL
cells	NULL
wire	NULL
isolated	NULL
,	NULL
transduced	NULL
,	NULL
and	NULL
incubated	NULL
for	NULL
5	NULL
d	NULL
in	NULL
IL-7	NULL
plus	NULL
SCF	NULL
.	NULL

After	NULL
the	NULL
in-cubation	NULL
,	NULL
GFP*	NULL
and	NULL
GFP-	NULL
cells	NULL
were	NULL
isolated	NULL
from	NULL
both	NULL
samples	NULL
using	NULL
a	NULL
FAC	NULL
Star®	NULL
.	NULL

Based	NULL
on	NULL
GFP	NULL
expression	NULL
,	NULL
the	NULL
purity	NULL
of	NULL
the	NULL
sorted	NULL
populations	NULL
was	NULL
>	NULL
99	NULL
%	NULL
.	NULL

DNA	NULL
was	NULL
prepared	NULL
after	NULL
the	NULL
sorting	NULL
and	NULL
analyzed	NULL
for	NULL
the	NULL
presence	NULL
of	NULL
D-JB	NULL
rearrangements	NULL
by	NULL
PCR	NULL
.	NULL

The	NULL
intensities	NULL
of	NULL
the	NULL
hybridized	NULL
band	NULL
were	NULL
determined	NULL
with	NULL
a	NULL
phosphorimager	NULL
(	NULL
Fujix	NULL
Bas	NULL
2000	NULL
;	NULL
R	NULL
aytest	NULL
Benelux	NULL
BV	NULL
,	NULL
Straubenherdt	NULL
,	NULL
FRG	NULL
)	NULL
.	NULL

The	NULL
ratios	NULL
of	NULL
D-J/	NULL
genomic	NULL
control	NULL
were	NULL
:	NULL
lane	NULL
1	NULL
,	NULL
0	NULL
;	NULL
lane	NULL
2	NULL
,	NULL
0.0025	NULL
;	NULL
lane	NULL
3	NULL
,	NULL
0	NULL
;	NULL
lane	NULL
4	NULL
,	NULL
0.035	NULL
;	NULL
lane	NULL
5	NULL
,	NULL
0.062	NULL
;	NULL
and	NULL
lane	NULL
6	NULL
,	NULL
0.028	NULL
.	NULL

$	NULL
8	NULL
G	NULL
a	NULL
``	NULL
&	NULL
&	NULL
&	NULL
Cs	NULL
8	NULL
$	NULL
£919	NULL
Id3	NULL
inhibits	NULL
the	NULL
IL-7	NULL
and	NULL
SCF-mediated	NULL
increase	NULL
DJB	NULL
rearrangements	NULL
in	NULL
CD1latCD34*	NULL
cells	NULL
.	NULL

It	NULL
appears	NULL
,	NULL
therefore	NULL
,	NULL
that	NULL
Id3	NULL
overexpression	NULL
inhibits	NULL
induction	NULL
of	NULL
D-JB	NULL
rear-rangement	NULL
.	NULL

It	NULL
remains	NULL
to	NULL
be	NULL
determined	NULL
whether	NULL
the	NULL
rearrangement	NULL
process	NULL
itself	NULL
is	NULL
blocked	NULL
or	NULL
whether	NULL
an	NULL
earlier	NULL
step	NULL
is	NULL
inhibited	NULL
.	NULL

Our	NULL
results	NULL
raise	NULL
the	NULL
possibility	NULL
that	NULL
the	NULL
SCF	NULL
receptor	NULL
(	NULL
ckit	NULL
)	NULL
and/	NULL
or	NULL
the	NULL
IL-7R	NULL
communicate	NULL
with	NULL
bHLH	NULL
factors	NULL
as	NULL
suggested	NULL
previously	NULL
(	NULL
14	NULL
)	NULL
.	NULL

The	NULL
Role	NULL
of	NULL
bHLH	NULL
Fadors	NULL
and	NULL
Id	NULL
Proteins	NULL
in	NULL
T	NULL
Cell	NULL
Development	NULL
.	NULL

-	NULL
The	NULL
results	NULL
presented	NULL
here	NULL
indicate	NULL
that	NULL
bHLH	NULL
proteins	NULL
are	NULL
involved	NULL
in	NULL
T	NULL
cell	NULL
commitment	NULL
.	NULL

The	NULL
critical	NULL
role	NULL
of	NULL
these	NULL
factors	NULL
in	NULL
T	NULL
cell	NULL
commitment	NULL
is	NULL
comparable	NULL
to	NULL
that	NULL
of	NULL
E2	NULL
A	NULL
proteins	NULL
in	NULL
commitment	NULL
of	NULL
B	NULL
cells	NULL
(	NULL
14	NULL
)	NULL
and	NULL
emphasizes	NULL
the	NULL
similarities	NULL
of	NULL
the	NULL
mechanisms	NULL
of	NULL
early	NULL
B	NULL
and	NULL
T	NULL
cell	NULL
development	NULL
(	NULL
27	NULL
)	NULL
.	NULL

Several	NULL
bHLH	NULL
factors	NULL
,	NULL
including	NULL
E2	NULL
,	NULL
HEB	NULL
,	NULL
and	NULL
E2-2	NULL
,	NULL
can	NULL
be	NULL
inhibited	NULL
in	NULL
their	NULL
action	NULL
by	NULL
overex-	NULL
pression	NULL
of	NULL
Id3	NULL
.	NULL

Mice	NULL
with	NULL
a	NULL
targeted	NULL
E2A	NULL
null	NULL
mutation	NULL
that	NULL
have	NULL
no	NULL
B	NULL
cells	NULL
were	NULL
initially	NULL
reported	NULL
to	NULL
have	NULL
no	NULL
apparent	NULL
gross	NULL
abnormalities	NULL
in	NULL
distribution	NULL
of	NULL
double	NULL
negative	NULL
(	NULL
DN	NULL
)	NULL
,	NULL
double	NULL
positive	NULL
(	NULL
DP	NULL
)	NULL
,	NULL
and	NULL
mature	NULL
thymocytes	NULL
;	NULL
however	NULL
,	NULL
the	NULL
thymi	NULL
of	NULL
these	NULL
mice	NULL
are	NULL
relatively	NULL
small	NULL
(	NULL
11	NULL
,	NULL
12	NULL
)	NULL
.	NULL

A	NULL
more	NULL
recent	NULL
analysis	NULL
of	NULL
the	NULL
effect	NULL
of	NULL
E2A	NULL
deficiency	NULL
on	NULL
T	NULL
cell	NULL
development	NULL
has	NULL
revealed	NULL
that	NULL
the	NULL
proportion	NULL
of	NULL
DP	NULL
cells	NULL
in	NULL
the	NULL
thymus	NULL
of	NULL
E2A~'~-	NULL
mice	NULL
is	NULL
lower	NULL
than	NULL
in	NULL
wild-type	NULL
or	NULL
heterozygous	NULL
'*	NULL
mice	NULL
.	NULL

Within	NULL
the	NULL
DN	NULL
population	NULL
,	NULL
an	NULL
accumulation	NULL
of	NULL
CD44*CD25~	NULL
cells	NULL
and	NULL
relatively	NULL
few	NULL
CD44	NULL
``	NULL
CD25	NULL
+cells	NULL
was	NULL
observed	NULL
(	NULL
28	NULL
)	NULL
.	NULL

Thus	NULL
it	NULL
appears	NULL
that	NULL
E2A	NULL
deficiency	NULL
results	NULL
in	NULL
a	NULL
partial	NULL
inhibition	NULL
of	NULL
the	NULL
CD25~	NULL
to	NULL
CD25*	NULL
transition	NULL
.	NULL

Most	NULL
interestingly	NULL
,	NULL
this	NULL
transition	NULL
is	NULL
equivalent	NULL
to	NULL
the	NULL
CD1a~	NULL
to	NULL
CD1at	NULL
transition	NULL
in	NULL
humans	NULL
(	NULL
Blom	NULL
,	NULL
B.	NULL
,	NULL
P.C.M	NULL
.	NULL

Res	NULL
,	NULL
and	NULL
H.	NULL
Spits	NULL
,	NULL
manuscript	NULL
in	NULL
preparation	NULL
)	NULL
that	NULL
is	NULL
blocked	NULL
by	NULL
Id3	NULL
.	NULL

HEB	NULL
may	NULL
be	NULL
another	NULL
target	NULL
for	NULL
Id3	NULL
.	NULL

Zhuang	NULL
et	NULL
al	NULL
.	NULL

observed	NULL
accumulation	NULL
of	NULL
DN	NULL
and	NULL
less	NULL
DP	NULL
thymocytes	NULL
in	NULL
the	NULL
thymus	NULL
of	NULL
HEB-	NULL
'	NULL
-	NULL
mice	NULL
(	NULL
18	NULL
)	NULL
.	NULL

Expression	NULL
of	NULL
the	NULL
CD3-TCR	NULL
complex	NULL
on	NULL
the	NULL
thymocytes	NULL
and	NULL
spleen	NULL
cells	NULL
of	NULL
the	NULL
HEB-deficient	NULL
mice	NULL
was	NULL
not	NULL
analyzed	NULL
,	NULL
leaving	NULL
the	NULL
developmental	NULL
stage	NULL
that	NULL
is	NULL
blocked	NULL
unresolved	NULL
.	NULL

It	NULL
is	NULL
possible	NULL
that	NULL
HEB	NULL
,	NULL
E2A	NULL
,	NULL
and	NULL
perhaps	NULL
other	NULL
bHLH	NULL
factors	NULL
collaborate	NULL
in	NULL
inducing	NULL
T	NULL
cell	NULL
development	NULL
,	NULL
and	NULL
that	NULL
a	NULL
complete	NULL
inhibition	NULL
ensues	NULL
when	NULL
these	NULL
factors	NULL
are	NULL
simultaneously	NULL
inhibited	NULL
by	NULL
overexpression	NULL
of	NULL
Id3	NULL
.	NULL

Thus	NULL
,	NULL
T	NULL
cell	NULL
development	NULL
may	NULL
be	NULL
dictated	NULL
by	NULL
a	NULL
combined	NULL
dosage	NULL
of	NULL
several	NULL
bHLH	NULL
factors	NULL
.	NULL

It	NULL
is	NULL
in	NULL
this	NULL
respect	NULL
noteworthy	NULL
that	NULL
B	NULL
cell	NULL
development	NULL
appears	NULL
to	NULL
be	NULL
regulated	NULL
by	NULL
the	NULL
combined	NULL
dosage	NULL
of	NULL
E2A	NULL
,	NULL
HEB	NULL
,	NULL
and	NULL
E2-2	NULL
proteins	NULL
(	NULL
18	NULL
)	NULL
.	NULL

Future	NULL
studies	NULL
should	NULL
provide	NULL
more	NULL
exact	NULL
information	NULL
about	NULL
which	NULL
bHLH	NULL
factors	NULL
are	NULL
critical	NULL
for	NULL
T	NULL
cell	NULL
development	NULL
and	NULL
which	NULL
genes	NULL
are	NULL
controlled	NULL
by	NULL
these	NULL
factors	NULL
.	NULL

We	NULL
thank	NULL
the	NULL
staff	NULL
of	NULL
the	NULL
Bloemenhovekliniek	NULL
in	NULL
Heemstede	NULL
(	NULL
Netherlands	NULL
)	NULL
for	NULL
their	NULL
cooperation	NULL
in	NULL
obtaining	NULL
fetal	NULL
tissue	NULL
.	NULL

We	NULL
thank	NULL
Dr.	NULL
Cees	NULL
Murre	NULL
for	NULL
providing	NULL
us	NULL
with	NULL
the	NULL
pCDN	NULL
AId3	NULL
plasmid	NULL
.	NULL

Dr.	NULL
A.	NULL
Venkitara-man	NULL
is	NULL
acknowledged	NULL
for	NULL
reviewing	NULL
the	NULL
manuscript	NULL
.	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
grants	NULL
from	NULL
the	NULL
Dutch	NULL
Cancer	NULL
Foundation	NULL
and	NULL
the	NULL
Netherlands	NULL
Organization	NULL
for	NULL
Scientific	NULL
R	NULL
esearch	NULL
(	NULL
NWO	NULL
)	NULL
.	NULL

Address	NULL
correspondence	NULL
to	NULL
Dr.	NULL
Hergen	NULL
Spits	NULL
,	NULL
Division	NULL
of	NULL
Immunology	NULL
,	NULL
The	NULL
Netherlands	NULL
Cancer	NULL
Institute	NULL
,	NULL
Plesmanlaan	NULL
121	NULL
,	NULL
1066	NULL
CX	NULL
Amsterdam	NULL
,	NULL
The	NULL
Netherlands	NULL
.	NULL

Phone	NULL
:	NULL
31-20-5122063	NULL
;	NULL
FAX	NULL
:	NULL
31-20-5122057	NULL
;	NULL
E-mail	NULL
:	NULL
hergen	NULL
@	NULL
nki.nl	NULL
Received	NULL
for	NULL
publication	NULL
7	NULL
July	NULL
1997	NULL
and	NULL
in	NULL
revised	NULL
form	NULL
21	NULL
August	NULL
1997	NULL
.	NULL

References	NULL
1	NULL
.	NULL

Spits	NULL
,	NULL
H.	NULL
,	NULL
L.	NULL
Lanier	NULL
,	NULL
and	NULL
J.H	NULL
.	NULL

Phillips	NULL
.	NULL

1995	NULL
.	NULL

Development	NULL
of	NULL
human	NULL
T	NULL
and	NULL
natural	NULL
killer	NULL
cells	NULL
.	NULL

Blood	NULL
.	NULL

$	NULL
5:2654-2670	NULL
.	NULL

2	NULL
.	NULL

Sanchez	NULL
,	NULL
M.-J	NULL
.	NULL

,	NULL
M.O	NULL
.	NULL

Muench	NULL
,	NULL
M.G	NULL
.	NULL

Roncarolo	NULL
,	NULL
L.	NULL
Lanier	NULL
,	NULL
and	NULL
J.	NULL
H.	NULL
Phillips	NULL
.	NULL

1994	NULL
.	NULL

Identification	NULL
of	NULL
a	NULL
common	NULL
T/	NULL
NK	NULL
cell	NULL
progenitor	NULL
in	NULL
human	NULL
fetal	NULL
thymus	NULL
.	NULL

J	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

180:569-576	NULL
.	NULL

3	NULL
.	NULL

Rodewald	NULL
,	NULL
HR	NULL
.	NULL

,	NULL
P.	NULL
Moingeon	NULL
,	NULL
J.L	NULL
.	NULL

Lucich	NULL
,	NULL
C.	NULL
Dosiou	NULL
,	NULL
P.	NULL
Lopez	NULL
,	NULL
and	NULL
EL	NULL
.	NULL

Reinherz	NULL
.	NULL

1992	NULL
.	NULL

A	NULL
population	NULL
of	NULL
early	NULL
fetal	NULL
thymocytes	NULL
expressing	NULL
Fe	NULL
gamma	NULL
R	NULL
II/	NULL
III	NULL
contains	NULL
precursors	NULL
1601	NULL
Heemskerk	NULL
et	NULL
al	NULL
.	NULL

of	NULL
T	NULL
lymphocytes	NULL
and	NULL
natural	NULL
killer	NULL
cells	NULL
.	NULL

Cell	NULL
.	NULL

69:139-150	NULL
.	NULL

4	NULL
.	NULL

Matsuzaki	NULL
,	NULL
Y.	NULL
,	NULL
J.-I	NULL
.	NULL

Gyotuku	NULL
,	NULL
M.	NULL
Ogawa	NULL
,	NULL
G.-I	NULL
.	NULL

Nishikawa	NULL
,	NULL
Y.	NULL
Katsura	NULL
,	NULL
G.	NULL
Gachelin	NULL
,	NULL
and	NULL
H.	NULL
Nakauchi	NULL
.	NULL

1993	NULL
.	NULL

Characterization	NULL
of	NULL
c-kit	NULL
positive	NULL
intrathymic	NULL
stem	NULL
cells	NULL
that	NULL
are	NULL
restricted	NULL
to	NULL
lymphoid	NULL
differentiation	NULL
.	NULL

J	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

178:1283-1292	NULL
.	NULL

5	NULL
.	NULL

Georgopoulos	NULL
,	NULL
K.	NULL
,	NULL
M.	NULL
Bigby	NULL
,	NULL
J.-H.	NULL
Wang	NULL
,	NULL
A.	NULL
Molnar	NULL
,	NULL
P.	NULL
Wu	NULL
,	NULL
S.	NULL
Winandy	NULL
,	NULL
and	NULL
A.	NULL
Sharpe	NULL
.	NULL

1994	NULL
.	NULL

The	NULL
Ikaros	NULL
gene	NULL
is	NULL
Brief	NULL
Definitive	NULL
R	NULL
eport	NULL
10	NULL
.	NULL

11	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17.	NULL
required	NULL
for	NULL
the	NULL
development	NULL
of	NULL
all	NULL
lymphoid	NULL
lineages	NULL
.	NULL

Cell	NULL
.	NULL

79:143-156.	NULL
.	NULL

Ting	NULL
,	NULL
C.-N.	NULL
,	NULL
M.C	NULL
.	NULL

Olson	NULL
,	NULL
K.P	NULL
.	NULL

Barton	NULL
,	NULL
and	NULL
J.M	NULL
.	NULL

Leiden	NULL
.	NULL

1997	NULL
.	NULL

Transcription	NULL
factor	NULL
GAT	NULL
A-3	NULL
is	NULL
required	NULL
for	NULL
development	NULL
of	NULL
the	NULL
T	NULL
cell	NULL
lineage	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

.	NULL

384:474-479.	NULL
.	NULL

Verbeek	NULL
,	NULL
S.	NULL
,	NULL
D.	NULL
Izon	NULL
,	NULL
F.	NULL
Hothuis	NULL
,	NULL
E.	NULL
Robanus	NULL
Maandag	NULL
,	NULL
H.	NULL
te	NULL
Riele	NULL
,	NULL
M.	NULL
van	NULL
de	NULL
Wetering	NULL
,	NULL
M.	NULL
Oosterwegel	NULL
,	NULL
A.	NULL
Wilson	NULL
,	NULL
H.R	NULL
.	NULL

MacDonald	NULL
,	NULL
and	NULL
H.	NULL
Clevers	NULL
.	NULL

1995	NULL
.	NULL

An	NULL
HMG-box-con-taining	NULL
T-cell	NULL
factor	NULL
required	NULL
for	NULL
thymocyte	NULL
differentiation	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

.	NULL

374:70-74.	NULL
.	NULL

Urbanek	NULL
,	NULL
P.	NULL
,	NULL
Z.Q	NULL
.	NULL

Wang	NULL
,	NULL
I.	NULL
Fetka	NULL
,	NULL
E.F.	NULL
Wagner	NULL
,	NULL
and	NULL
M.	NULL
Busslinger	NULL
.	NULL

1994	NULL
.	NULL

Complete	NULL
block	NULL
of	NULL
early	NULL
B	NULL
cell	NULL
differentiation	NULL
and	NULL
altered	NULL
patterning	NULL
of	NULL
the	NULL
posterior	NULL
midbrain	NULL
in	NULL
mice	NULL
lacking	NULL
Pax5/	NULL
BSAP	NULL
.	NULL

Cell	NULL
.	NULL

79:901-912.	NULL
.	NULL

Lin	NULL
,	NULL
H.	NULL
,	NULL
and	NULL
R.	NULL
Grosschedl	NULL
.	NULL

1995	NULL
.	NULL

Failure	NULL
of	NULL
B-cell	NULL
differenti-	NULL
ation	NULL
in	NULL
mice	NULL
lacking	NULL
the	NULL
transcription	NULL
factor	NULL
EBF	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

.	NULL

376:263-267	NULL
.	NULL

Schilham	NULL
,	NULL
M.W	NULL
.	NULL

,	NULL
M.A	NULL
.	NULL

Oosterwegel	NULL
,	NULL
P.	NULL
Moerer	NULL
,	NULL
J	NULL
.	NULL

Ya	NULL
,	NULL
P.	NULL
de	NULL
Boer	NULL
,	NULL
M.	NULL
van	NULL
de	NULL
Wetering	NULL
,	NULL
S.	NULL
Verbeek	NULL
,	NULL
W.H	NULL
.	NULL

Lamers	NULL
,	NULL
A.M.	NULL
Kruisbeek	NULL
,	NULL
A.	NULL
Cumano	NULL
,	NULL
and	NULL
H.	NULL
Clevers	NULL
.	NULL

1996	NULL
.	NULL

Defects	NULL
in	NULL
cardiac	NULL
outflow	NULL
tract	NULL
formation	NULL
and	NULL
pro-B-lymphocyte	NULL
expansion	NULL
in	NULL
mice	NULL
lacking	NULL
Sox-4	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

.	NULL

380:71	NULL
1-714	NULL
.	NULL

Zhuang	NULL
,	NULL
Y.	NULL
,	NULL
P.	NULL
Soriano	NULL
,	NULL
and	NULL
H.	NULL
Weintraub	NULL
.	NULL

1994	NULL
.	NULL

The	NULL
helix-loop-helix	NULL
gene	NULL
E2A	NULL
is	NULL
required	NULL
for	NULL
B	NULL
cell	NULL
formation	NULL
.	NULL

Cell	NULL
.	NULL

79:875-884	NULL
.	NULL

Bain	NULL
,	NULL
G.	NULL
,	NULL
E.	NULL
Robanus	NULL
Maandag	NULL
,	NULL
D.J	NULL
.	NULL

Izon	NULL
,	NULL
D.	NULL
Amsen	NULL
,	NULL
A.M.	NULL
Kruisbeek	NULL
,	NULL
B.C	NULL
.	NULL

Weintraub	NULL
,	NULL
I.	NULL
Krop	NULL
,	NULL
L.	NULL
Schlissel	NULL
,	NULL
AJ	NULL
.	NULL

Feeney	NULL
,	NULL
M.	NULL
van	NULL
Roon	NULL
,	NULL
and	NULL
C.	NULL
Murre	NULL
.	NULL

1994	NULL
.	NULL

EZ2A	NULL
proteins	NULL
are	NULL
required	NULL
for	NULL
proper	NULL
B	NULL
cell	NULL
development	NULL
and	NULL
initiation	NULL
of	NULL
Ig	NULL
gene	NULL
rearrangements	NULL
.	NULL

Coll	NULL
.	NULL

79:885-892	NULL
.	NULL

Murre	NULL
,	NULL
C.	NULL
,	NULL
G.	NULL
Bain	NULL
,	NULL
M.K	NULL
.	NULL

van	NULL
Dijk	NULL
,	NULL
L.	NULL
Engel	NULL
,	NULL
B.A	NULL
.	NULL

Furnari	NULL
,	NULL
ME	NULL
.	NULL

Massari	NULL
,	NULL
JR.	NULL
Matthews	NULL
,	NULL
M.W	NULL
.	NULL

Quong	NULL
,	NULL
RR	NULL
.	NULL

Rivera	NULL
,	NULL
and	NULL
M.H	NULL
.	NULL

Stuiver	NULL
.	NULL

1994	NULL
.	NULL

Structure	NULL
and	NULL
function	NULL
of	NULL
helix-loop-helix	NULL
proteins	NULL
.	NULL

Biochim	NULL
.	NULL

Biophys	NULL
.	NULL

Aaa	NULL
.	NULL

1218:129-135	NULL
.	NULL

Bain	NULL
,	NULL
G.	NULL
,	NULL
E.	NULL
Robanus	NULL
Maandag	NULL
,	NULL
H.	NULL
te	NULL
Riele	NULL
,	NULL
A.J	NULL
.	NULL

Feeney	NULL
,	NULL
A.	NULL
Sheehy	NULL
,	NULL
M.	NULL
Schlissel	NULL
,	NULL
S.A.	NULL
Shinton	NULL
,	NULL
R.R	NULL
.	NULL

Hardy	NULL
,	NULL
and	NULL
C.	NULL
Murre	NULL
.	NULL

1997	NULL
.	NULL

Both	NULL
E12	NULL
and	NULL
E47	NULL
allow	NULL
commitment	NULL
to	NULL
the	NULL
B	NULL
cell	NULL
lineage	NULL
.	NULL

Immunity	NULL
.	NULL

6:145-154	NULL
.	NULL

Benezra	NULL
,	NULL
R.	NULL
,	NULL
R.L	NULL
.	NULL

Davis	NULL
,	NULL
D.	NULL
Lockshon	NULL
,	NULL
D.L	NULL
.	NULL

Turner	NULL
,	NULL
and	NULL
H.	NULL
Weintraub	NULL
.	NULL

1990	NULL
.	NULL

The	NULL
protein	NULL
Id	NULL
:	NULL
a	NULL
negative	NULL
regulator	NULL
of	NULL
helix-loop-helix	NULL
DNA	NULL
binding	NULL
proteins	NULL
.	NULL

Cell	NULL
.	NULL

61:49-59	NULL
.	NULL

Riechmann	NULL
,	NULL
V.	NULL
,	NULL
I.	NULL
van	NULL
Cruchten	NULL
,	NULL
and	NULL
F.	NULL
Sablitzky	NULL
.	NULL

1994	NULL
.	NULL

The	NULL
expression	NULL
pattern	NULL
of	NULL
Id4	NULL
,	NULL
a	NULL
novel	NULL
dominant	NULL
negative	NULL
helix-loop-helix	NULL
protein	NULL
,	NULL
is	NULL
distinct	NULL
from	NULL
Id1	NULL
,	NULL
Id2	NULL
and	NULL
Id3	NULL
.	NULL

Nudeic	NULL
Adds	NULL
Res	NULL
.	NULL

22:749-755	NULL
.	NULL

Sun	NULL
,	NULL
X.H	NULL
.	NULL

1994	NULL
.	NULL

Constitutive	NULL
expression	NULL
of	NULL
the	NULL
Id1	NULL
gene	NULL
impairs	NULL
mouse	NULL
B	NULL
cell	NULL
development	NULL
.	NULL

Cell	NULL
.	NULL

79:893-900	NULL
.	NULL

1602	NULL
18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

Zhuang	NULL
,	NULL
Y.	NULL
,	NULL
P.	NULL
Cheng	NULL
,	NULL
and	NULL
H.	NULL
Weintraub	NULL
.	NULL

1996	NULL
.	NULL

B	NULL
lympho-cyte	NULL
development	NULL
is	NULL
regulated	NULL
by	NULL
the	NULL
combined	NULL
dosage	NULL
of	NULL
three	NULL
basic-	NULL
helix-loop-helix	NULL
genes	NULL
,	NULL
E2A	NULL
,	NULL
E2-2	NULL
and	NULL
HEB	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

16:2898-2905	NULL
.	NULL

Loveys	NULL
,	NULL
D.A	NULL
.	NULL

,	NULL
M.B	NULL
.	NULL

Streiff	NULL
,	NULL
and	NULL
G.J	NULL
.	NULL

Kato	NULL
.	NULL

1996	NULL
.	NULL

E2A	NULL
basic-helix-loop-helix	NULL
transcription	NULL
factors	NULL
are	NULL
negatively	NULL
regulated	NULL
by	NULL
serum	NULL
growth	NULL
factors	NULL
and	NULL
by	NULL
the	NULL
Id3	NULL
protein	NULL
.	NULL

Nudeic	NULL
A	NULL
ads	NULL
Res	NULL
.	NULL

24:2813-2820	NULL
.	NULL

Staal	NULL
,	NULL
FJ.T	NULL
.	NULL

,	NULL
A.Q	NULL
.	NULL

Bakker	NULL
,	NULL
M.	NULL
Verkuylen	NULL
,	NULL
E.	NULL
van	NULL
Oort	NULL
,	NULL
and	NULL
H.	NULL
Spits	NULL
.	NULL

1996	NULL
.	NULL

Use	NULL
of	NULL
bicistronic	NULL
retroviral	NULL
vectors	NULL
encoding	NULL
the	NULL
LacZ	NULL
gene	NULL
together	NULL
with	NULL
a	NULL
gene	NULL
of	NULL
interest	NULL
:	NULL
a	NULL
method	NULL
to	NULL
select	NULL
producer	NULL
cells	NULL
and	NULL
follow	NULL
transduced	NULL
target	NULL
cells	NULL
Caner	NULL
Gene	NULL
Ther	NULL
.	NULL

3:345-351	NULL
.	NULL

Kinsella	NULL
,	NULL
TM	NULL
.	NULL

,	NULL
and	NULL
G.P	NULL
.	NULL

Nolan	NULL
.	NULL

1996	NULL
.	NULL

Episomal	NULL
vectors	NULL
rapidly	NULL
and	NULL
stably	NULL
produce	NULL
high-titer	NULL
recombinant	NULL
retrovirus	NULL
.	NULL

Hum	NULL
.	NULL

Gene	NULL
Therapy	NULL
.	NULL

7:1405-1413	NULL
.	NULL

Res	NULL
,	NULL
P.	NULL
,	NULL
E.	NULL
Martinez	NULL
Caceres	NULL
,	NULL
A.C.	NULL
Jaleco	NULL
,	NULL
E.	NULL
Noteboom	NULL
,	NULL
K.	NULL
Weijer	NULL
,	NULL
and	NULL
H.	NULL
Spits	NULL
.	NULL

1996	NULL
.	NULL

CD34*CD38	NULL
``	NULL
cells	NULL
in	NULL
the	NULL
human	NULL
thymus	NULL
can	NULL
differentiate	NULL
into	NULL
T	NULL
,	NULL
natural	NULL
killer	NULL
and	NULL
den-dritic	NULL
cells	NULL
but	NULL
are	NULL
distinct	NULL
from	NULL
stem	NULL
cells	NULL
Blood	NULL
87:5196-5206	NULL
.	NULL

Yssel	NULL
,	NULL
H.	NULL
,	NULL
J.E	NULL
.	NULL

De	NULL
Vries	NULL
,	NULL
M.	NULL
Koken	NULL
,	NULL
W.	NULL
van	NULL
Blitterswijk	NULL
,	NULL
and	NULL
H.	NULL
Spits	NULL
1984	NULL
.	NULL

Serum-free	NULL
medium	NULL
for	NULL
the	NULL
generation	NULL
and	NULL
the	NULL
propagation	NULL
of	NULL
functional	NULL
human	NULL
cytotoxic	NULL
and	NULL
helper	NULL
T	NULL
cell	NULL
clones	NULL
.	NULL

J	NULL
Immunol	NULL
.	NULL

Methods	NULL
.	NULL

72:219-227	NULL
.	NULL

Res	NULL
,	NULL
P.	NULL
,	NULL
B.	NULL
Blom	NULL
,	NULL
T.	NULL
Hori	NULL
,	NULL
E.	NULL
Noteboom	NULL
,	NULL
K.	NULL
Weijer	NULL
,	NULL
and	NULL
H.	NULL
Spits	NULL
.	NULL

1997	NULL
.	NULL

Downregulation	NULL
of	NULL
CD1a	NULL
marks	NULL
acquisition	NULL
of	NULL
functional	NULL
competence	NULL
by	NULL
human	NULL
thymocytes	NULL
and	NULL
marks	NULL
a	NULL
novel	NULL
control	NULL
point	NULL
in	NULL
a	NULL
late	NULL
stage	NULL
of	NULL
human	NULL
T	NULL
cell	NULL
development	NULL
.	NULL

J	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

185:141-152	NULL
.	NULL

Blom	NULL
,	NULL
B.	NULL
,	NULL
P.	NULL
Res	NULL
,	NULL
E.	NULL
Noteboom	NULL
,	NULL
K.	NULL
Weijer	NULL
and	NULL
H.	NULL
Spits	NULL
.	NULL

1997	NULL
.	NULL

Prethymic	NULL
CD34*	NULL
progenitors	NULL
capable	NULL
of	NULL
developing	NULL
into	NULL
T	NULL
cells	NULL
are	NULL
not	NULL
committed	NULL
to	NULL
the	NULL
T	NULL
cell	NULL
lineage	NULL
.	NULL

J	NULL
Immunol	NULL
.	NULL

158:3571-3577	NULL
.	NULL

Ramiro	NULL
,	NULL
AR	NULL
.	NULL

,	NULL
C.	NULL
Trigueros	NULL
,	NULL
C.	NULL
Marquez	NULL
,	NULL
J.L	NULL
.	NULL

San	NULL
Milan	NULL
,	NULL
and	NULL
M.L	NULL
.	NULL

Toribio	NULL
.	NULL

1996	NULL
.	NULL

Regulation	NULL
of	NULL
pre-T	NULL
cell	NULL
receptor	NULL
(	NULL
pT	NULL
«	NULL
-TCR	NULL
B	NULL
)	NULL
gene	NULL
expression	NULL
during	NULL
human	NULL
thymic	NULL
development	NULL
.	NULL

J	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

184	NULL
;	NULL
519-530	NULL
.	NULL

Borst	NULL
,	NULL
J.	NULL
,	NULL
H.	NULL
Jacobs	NULL
,	NULL
and	NULL
G.	NULL
Brouns	NULL
.	NULL

1996	NULL
.	NULL

Composition	NULL
and	NULL
function	NULL
of	NULL
T-cell	NULL
and	NULL
B-cell	NULL
receptor	NULL
complexes	NULL
on	NULL
precursor	NULL
lymphocytes	NULL
.	NULL

Cur	NULL
:	NULL
Opin	NULL
.	NULL

Immunol	NULL
.	NULL

8:181-190	NULL
.	NULL

Bain	NULL
,	NULL
G.	NULL
,	NULL
I.	NULL
Engel	NULL
,	NULL
E.C	NULL
.	NULL

Robanus	NULL
Maandag	NULL
,	NULL
H.P.J	NULL
.	NULL

te	NULL
Riele	NULL
,	NULL
JR.	NULL
Voland	NULL
,	NULL
LL	NULL
.	NULL

Sharp	NULL
,	NULL
J.	NULL
Ghun	NULL
,	NULL
B.	NULL
Huey	NULL
,	NULL
D.	NULL
Pinkel	NULL
,	NULL
and	NULL
C.	NULL
Murre	NULL
.	NULL

1997	NULL
.	NULL

E2A	NULL
deficiency	NULL
leads	NULL
to	NULL
abnormalities	NULL
in	NULL
«	NULL
B	NULL
T-cell	NULL
development	NULL
and	NULL
to	NULL
rapid	NULL
development	NULL
of	NULL
T-cell	NULL
lym-phomas	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

17:4782-4791	NULL
.	NULL

Id3	NULL
Inhibits	NULL
Human	NULL
T	NULL
Cell	NULL
Development	NULL

